AI Can Help Accelerate Commercialization Strategies
Main Ideas:
- Decision support in process development is crucial for advanced therapies.
- Artificial intelligence (AI) can enable robust manufacturing and help bring new drugs to the market.
- Advanced therapies have fewer established processes and complex product development.
- AI can fill the gap in background knowledge for these new drugs.
Author’s Take:
Artificial intelligence is becoming a valuable tool in the commercialization of advanced therapies. With the complexity and lack of established processes in these new drugs, AI can provide decision support and help ensure robust manufacturing. By filling the knowledge gap, AI has the potential to accelerate the development and commercialization of these innovative treatments.